Key result
On-pump beating-heart CABG demonstrated a 97.5% survival rate at 6 months, with no postoperative myocardial infarctions or kidney dysfunction reported.
Observational (n=80)
No
On-pump beating-heart CABG demonstrates acceptable short-term mortality and morbidity outcomes in patients with coronary artery disease.
Background: This paper intends to evaluate the effects of on-pump beating-heart coronary artery bypass graft (CABG) in patients with coronary artery disease. Studies have shown that this surgical procedure can have acceptable results. Objectives: This study intends to share experiences and results of on-pump beating-heart CABG. Methods: We reported preliminary results related to mortality and morbidity in patients who underwent CABG in the period from 2015 to 2017 in Ghaem hospital, Mashhad, Iran. Results: 80 patients, in the period from 2015to 2017, underwent general anesthesia and on-pump beating-heart CABG surgery was done for them. The average number of grafts was 3.18± 0.474 and two patients died, unfortunately: one during surgery and one in ICU. There were no postoperative myocardial infarctions during the study. None of the patients reported kidney dysfunction. The average length of hospitalization was 4±1.11 days and the mean follow-up of the patients was 6 months. The average ejection fraction (EF) of patients was 43. 28± 9.58. Conclusion: In the last decade there has been a big challenge between using off-pump CABG and on-pump CABG, on-pump beating method could present acceptable and effective results.
No takes yet. Share an insight, caveat, or question.
Rouhandeh et al. (2018) conducted an observational in Coronary artery disease (n=80). On-pump beating-heart CABG was evaluated on Mortality. On-pump beating-heart CABG demonstrated a 97.5% survival rate at 6 months, with no postoperative myocardial infarctions or kidney dysfunction reported.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: